
-
抗体試薬
- フローサイトメトリー用試薬
-
ウェスタンブロッティング抗体試薬
- イムノアッセイ試薬
-
シングルセル試薬
- BD® AbSeq Assay
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Immune Profiler Protein Panel
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD® OMICS-Guard Sample Preservation Buffer
- BD Rhapsody™ ATAC-Seq Assays
- BD® OMICS-One Protein Panels
-
細胞機能評価のための試薬
-
顕微鏡・イメージング用試薬
-
細胞調製・分離試薬
-
- BD® AbSeq Assay
- BD Rhapsody™ Accessory Kits
- BD® OMICS-One Immune Profiler Protein Panel
- BD® Single-Cell Multiplexing Kit
- BD Rhapsody™ TCR/BCR Next Multiomic Assays
- BD Rhapsody™ Targeted mRNA Kits
- BD Rhapsody™ Whole Transcriptome Analysis (WTA) Amplification Kit
- BD® OMICS-Guard Sample Preservation Buffer
- BD Rhapsody™ ATAC-Seq Assays
- BD® OMICS-One Protein Panels
- Japan (Japanese)
-
Change country/language
Old Browser
Looks like you're visiting us from United States.
Would you like to stay on the current country site or be switched to your country?
BD Horizon™ BV421 Mouse Anti-Human Myeloperoxidase
クローン 5B8 (RUO)

Multiparameter flow cytometric analysis of Myeloperoxidase expression in Human peripheral blood leukocyte populations. Human whole blood was treated with BD Phosflow™ Lyse/Fix Buffer (Cat. No. 558049) to lyse erythrocytes and fix leucocytes. The fixed leucocytes were washed and then permeabilized with BD Perm/Wash™ Buffer (Cat. No. 554723). The permeabilized cells were stained in BD Perm/Wash™ Buffer with either BD Horizon™ BV421 Mouse IgG1, κ Isotype Control (Cat. No. 569394; Left Plot) or BD Horizon™ BV421 Mouse Anti-Human Myeloperoxidase antibody (Cat. No. 570039/570120; Right Plot). The bivariate pseudocolor density plot showing the correlated expression of Myeloperoxidase (or Ig Isotype control staining) versus side-light scatter (SSC-A) signals was derived from gated events with the forward and side light-scatter characteristics of intact leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ Software.


Multiparameter flow cytometric analysis of Myeloperoxidase expression in Human peripheral blood leukocyte populations. Human whole blood was treated with BD Phosflow™ Lyse/Fix Buffer (Cat. No. 558049) to lyse erythrocytes and fix leucocytes. The fixed leucocytes were washed and then permeabilized with BD Perm/Wash™ Buffer (Cat. No. 554723). The permeabilized cells were stained in BD Perm/Wash™ Buffer with either BD Horizon™ BV421 Mouse IgG1, κ Isotype Control (Cat. No. 569394; Left Plot) or BD Horizon™ BV421 Mouse Anti-Human Myeloperoxidase antibody (Cat. No. 570039/570120; Right Plot). The bivariate pseudocolor density plot showing the correlated expression of Myeloperoxidase (or Ig Isotype control staining) versus side-light scatter (SSC-A) signals was derived from gated events with the forward and side light-scatter characteristics of intact leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ Software.

Multiparameter flow cytometric analysis of Myeloperoxidase expression in Human peripheral blood leukocyte populations. Human whole blood was treated with BD Phosflow™ Lyse/Fix Buffer (Cat. No. 558049) to lyse erythrocytes and fix leucocytes. The fixed leucocytes were washed and then permeabilized with BD Perm/Wash™ Buffer (Cat. No. 554723). The permeabilized cells were stained in BD Perm/Wash™ Buffer with either BD Horizon™ BV421 Mouse IgG1, κ Isotype Control (Cat. No. 569394; Left Plot) or BD Horizon™ BV421 Mouse Anti-Human Myeloperoxidase antibody (Cat. No. 570039/570120; Right Plot). The bivariate pseudocolor density plot showing the correlated expression of Myeloperoxidase (or Ig Isotype control staining) versus side-light scatter (SSC-A) signals was derived from gated events with the forward and side light-scatter characteristics of intact leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ Software.


BD Horizon™ BV421 Mouse Anti-Human Myeloperoxidase

Regulatory Statusの凡例
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Preparation and Storage
推奨アッセイ手順
BD® CompBeads can be used as surrogates to assess fluorescence spillover (compensation). When fluorochrome conjugated antibodies are bound to BD® CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD® CompBeads to ensure that BD® CompBeads are appropriate for your specific cellular application.
For optimal and reproducible results, BD Horizon Brilliant Stain Buffer should be used anytime BD Horizon Brilliant dyes are used in a multicolor flow cytometry panel. Fluorescent dye interactions may cause staining artifacts which may affect data interpretation. The BD Horizon Brilliant Stain Buffer was designed to minimize these interactions. When BD Horizon Brilliant Stain Buffer is used in in the multicolor panel, it should also be used in the corresponding compensation controls for all dyes to achieve the most accurate compensation. For the most accurate compensation, compensation controls created with either cells or beads should be exposed to BD Horizon Brilliant Stain Buffer for the same length of time as the corresponding multicolor panel. More information can be found in the Technical Data Sheet of the BD Horizon Brilliant Stain Buffer (Cat. No. 563794/566349) or the BD Horizon Brilliant Stain Buffer Plus (Cat. No. 566385).
Product Notices
- Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
- This reagent has been pre-diluted for use at the recommended Volume per Test. We typically use 1 × 10^6 cells in a 100-µl experimental sample (a test).
- An isotype control should be used at the same concentration as the antibody of interest.
- Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
- For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
- Human donor specific background has been observed in relation to the presence of anti-polyethylene glycol (PEG) antibodies, developed as a result of certain vaccines containing PEG, including some COVID-19 vaccines. We recommend use of BD Horizon Brilliant™ Stain Buffer in your experiments to help mitigate potential background. For more information visit https://www.bdbiosciences.com/en-us/support/product-notices.
- Please refer to http://regdocs.bd.com to access safety data sheets (SDS).
- For U.S. patents that may apply, see bd.com/patents.
関連製品






The 5B8 monoclonal antibody specifically recognizes Myeloperoxidase (MPO). Enzymatically active Myeloperoxidase exists as a heterotetrameric glycoprotein comprised of two disulfide-linked heterodimers with each having a heavy (~55 kDa) and light (~15 kDa) subunit associated with a heme-like prosthetic group. Myeloperoxidase is stored in primary azurophilic granules of neutrophils and is rapidly released into the phagosome and extracellular space during inflammatory responses. It is also present in monocytes and in myeloblasts from some cases of acute myeloid leukemia. Myeloperoxidase catalyzes the generation of hypochlorous acid, a powerful oxidant and potent microbicidal agent. It plays a major role in the bactericidal activity of neutrophils and monocytes.

Development References (7)
-
Audrain MA, Baranger TA, Moguilevski N, et al. Anti-native and recombinant myeloperoxidase monoclonals and human autoantibodies. Clin Exp Immunol. 1997; 107(1):127-134. (Immunogen: Blocking, ELISA, Western blot). View Reference
-
He Z, Allers C, Sugimoto C, et al. Rapid Turnover and High Production Rate of Myeloid Cells in Adult Rhesus Macaques with Compensations during Aging.. J Immunol. 2018; 200(12):4059-4067. (Clone-specific: Flow cytometry). View Reference
-
Knapp W, Strobl H, Majdic O. Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. Cytometry. 1994; 18(4):187-198. (Biology). View Reference
-
Raskovalova T, Berger MG, Jacob MC, et al. Flow cytometric analysis of neutrophil myeloperoxidase expression in peripheral blood for ruling out myelodysplastic syndromes: a diagnostic accuracy study.. Haematologica. 2019; 104(12):2382-2390. (Clone-specific: Flow cytometry). View Reference
-
Taylor KL, Pohl J, Kinkade JM. Unique autolytic cleavage of human myeloperoxidase. Implications for the involvement of active site MET409.. J Biol Chem. 1992; 267(35):25282-8. (Biology). View Reference
-
Tobler A, Miller CW, Johnson KR, Selsted ME, Rovera G, Koeffler HP. Regulation of gene expression of myeloperoxidase during myeloid differentiation. J Cellular Physiol. 1988; 136:215-225. (Biology).
-
van de Vyver M, Engelbrecht L, Smith C, Myburgh KH. Neutrophil and monocyte responses to downhill running: Intracellular contents of MPO, IL-6, IL-10, pstat3, and SOCS3.. Scand J Med Sci Sports. 2016; 26(6):638-47. (Clone-specific: Flow cytometry). View Reference
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.